| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8714893 | Journal of the American Academy of Dermatology | 2018 | 36 Pages |
Abstract
Both certolizumab regimens improved psoriasis symptoms, with a greater response seen with the higher dose. No new safety signals were observed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Mark MD, Andrew MD, MBA, Carle MD, PhD, Howard MD, Jolanta MD, Vincent MD, Daniel MD, Robert PharmD, Janice MPH, Luke MS, Matthias MD,